Can Lu177 PSMA Therapy can reduce pain ? - PowerPoint PPT Presentation

About This Presentation
Title:

Can Lu177 PSMA Therapy can reduce pain ?

Description:

Most Advanced Prostate Cancer patients who have undergone Alpha PSMA Therapy have experienced a remarkable improvement in their quality of life with reduced symptoms and pain. – PowerPoint PPT presentation

Number of Views:99

less

Transcript and Presenter's Notes

Title: Can Lu177 PSMA Therapy can reduce pain ?


1
Research has shown that in men with metastatic
castration-resistant prostate cancer who have
progressed after conventional therapies, Lu177
PSMA Therapy not only has high response rates,
low toxic effects, but most importantly reduced
pain.
2
Alpha (Ac225) PSMA Therapy is an effective
treatment modality for men with metastatic
castration resistant prostate cancer (mCRPC). It
helps improve quality of life by decreasing tumor
growth rate and reducing pain.
3
The Department of Nuclear Medicine at Fortis
Memorial Research Institute (FMRI), Gurugram,
India, has treated more than 30 new patients of
Castration Resistance Prostate Cancer (CRPC) with
Ac225 PSMA Therapy. The results are extremely
promising with 75-80 of patients showing
evidences of significant radiological and
biochemical response with prolonged duration of
response.
4
Ac-225-PSMA Therapy is a safe and tolerable
treatment option for metastatic
castration-resistant prostate cancer (mCRPC)
patients who have been previously treated with
chemotherapy. Trials and research have shown that
significant improvement in survival and quality
of life can be achieved even in patients with
residual disease which otherwise have very
limited options.
5
Alpha PSMA Therapy has been proven effective for
patients with advanced prostate cancer for whom
surgical and other medical options have already
exhausted themselves. They offer a new ray of
hope. The Department of Nuclear Medicine at
Fortis Memorial Research Institute (FMRI),
Gurugram, India, has treated more than 30 new
patients of Castration Resistance Prostate Cancer
(CRPC) with Ac225 PSMA Therapy. The results are
extremely promising with 75-80 of patients
showing evidences of significant radiological and
biochemical response with prolonged duration of
response.
6
  • For more information on the efficacy of Actinium
    225 PSMA Therapy do call us at 91 98111 27080,or
    write to us at info_at_nuclearmedicinetherapy.in or
    visit https//nuclearmedicinetherapy.in/treatments
    /alpha-psma-therapy
Write a Comment
User Comments (0)
About PowerShow.com